Waghorn D J
Department of Microbiology, Wycombe General Hospital, Buckinghamshire, UK.
J Clin Pathol. 2001 Mar;54(3):214-8. doi: 10.1136/jcp.54.3.214.
Patients without spleens are at increased risk of overwhelming infection. Recently, greater efforts, including the publication of national guidelines, have been made to improve the management of asplenic individuals. In theory, risks of serious sepsis can be reduced by good advice, immunisation, and antibiotic prophylaxis. In practice, such preventive measures might not be followed or may fail. A study of recent cases of overwhelming postsplenectomy infection (OPSI) was undertaken to examine specific associated factors and to determine whether currently recommended preventive measures are being followed.
Cases of OPSI were identified and reported mainly by microbiologists across the country using a specifically designed proforma. Data including the nature of the infection and vaccination/ antibiotic prophylaxis history since splenectomy were obtained.
Seventy seven cases were reported. The age range varied from 3 months (congenital asplenia) to 87 years. In those who had undergone surgical splenectomy, the time interval between surgery and OPSI varied from 24 days to 65 years. Overall mortality reached 50%, with underlying haematological malignancy associated with the highest death rate. Streptococcus pneumoniae caused approximately 90% episodes. Only 31% individuals had received pneumococcal vaccination before OPSI. Seven of 17 pneumococcal infections in immunised cases could be considered vaccine failures. Few patients had been adequately advised on antibiotic prophylaxis or other measures.
Currently accepted best practice for managing asplenic patients is not being followed. Some OPSI cases may still be preventable but many asplenic individuals remain unrecognised. The compilation of asplenic patient registers might help to implement agreed policies with audit necessary to evaluate compliance. More is needed to ensure optimal management for this cohort of the population.
无脾患者发生暴发性感染的风险增加。最近,人们做出了更大努力,包括发布国家指南,以改善对无脾个体的管理。理论上,通过良好的建议、免疫接种和抗生素预防可以降低严重脓毒症的风险。但在实际中,这些预防措施可能未被遵循或可能失败。开展了一项关于近期脾切除术后暴发性感染(OPSI)病例的研究,以检查具体相关因素,并确定目前推荐的预防措施是否得到遵循。
主要由全国各地的微生物学家使用专门设计的表格识别和报告OPSI病例。获取了包括感染性质以及脾切除术后的疫苗接种/抗生素预防史等数据。
共报告了77例病例。年龄范围从3个月(先天性无脾)到87岁。在接受手术脾切除的患者中,手术与OPSI之间的时间间隔从24天到65年不等。总体死亡率达到50%,潜在血液系统恶性肿瘤患者的死亡率最高。肺炎链球菌导致了约90%的感染发作。只有31%的个体在发生OPSI之前接种过肺炎球菌疫苗。在接种疫苗的病例中,17例肺炎球菌感染中有7例可被视为疫苗接种失败。很少有患者得到关于抗生素预防或其他措施的充分建议。
目前公认的无脾患者最佳管理做法未得到遵循。一些OPSI病例可能仍然可以预防,但许多无脾个体仍未被识别。编制无脾患者登记册可能有助于实施商定的政策,并进行评估合规性所需的审核。需要更多措施来确保对这一人群的最佳管理。